227 related articles for article (PubMed ID: 22371643)
1. Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.
Zheng XY; Wei RB; Tang L; Li P; Zheng XD
World J Gastroenterol; 2012 Feb; 18(8):821-32. PubMed ID: 22371643
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of the efficacy and safety of nucleotide/nucleoside analog monotherapy for hepatitis B virus-associated glomerulonephritis.
Wang WN; Wu MY; Ma FZ; Sun T; Xu ZG
Clin Nephrol; 2016 Jan; 85(1):21-9. PubMed ID: 26636326
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.
Zhang Y; Zhou JH; Yin XL; Wang FY
World J Gastroenterol; 2010 Feb; 16(6):770-7. PubMed ID: 20135728
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Serum DNA Replication, Clinicopathological Characteristics and Prognosis of Hepatitis B Virus-associated Glomerulonephritis with Severe Proteinuria by Lamivudine Plus Adefovir Dipivoxil Combination Therapy.
Jiang W; Liu T; Dong H; Xu Y; Liu LQ; Guan GJ; Liu XC
Biomed Environ Sci; 2015 Mar; 28(3):206-13. PubMed ID: 25800445
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological characteristics of 5 children with HBV surface antigen (HBsAg)-negative hepatitis B virus-associated glomerulonephritis.
Liu T; Yang S; Yue Z; Kuang Y; Guan W; Sun L
J Clin Virol; 2015 May; 66():1-5. PubMed ID: 25866326
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of tacrolimus and entecavir combination therapy in the treatment of hepatitis B virus-associated glomerulonephritis: a multi-center, placebo controlled, and single-blind randomized trial.
Xie XF; Xie BY; Zhang WH; Hou JH; Liu DL; Zhang L; Xu LX; Li ZL; Li RZ; Ye ZM
Ann Palliat Med; 2022 May; 11(5):1762-1773. PubMed ID: 35672893
[TBL] [Abstract][Full Text] [Related]
7. Treatment of hepatitis B virus associated glomerulonephritis with recombinant human alpha interferon.
Chung DR; Yang WS; Kim SB; Yu E; Chung YH; Lee Y; Park JS
Am J Nephrol; 1997; 17(2):112-7. PubMed ID: 9096440
[TBL] [Abstract][Full Text] [Related]
8. A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in Chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: a prospective cohort study.
Li X; Tian J; Wu J; He Q; Li H; Han F; Li Q; Chen Y; Ni Q; Chen J
Clin Ther; 2009 Apr; 31(4):741-50. PubMed ID: 19446147
[TBL] [Abstract][Full Text] [Related]
9. Interferon therapy for HCV-associated glomerulonephritis: meta-analysis of controlled trials.
Fabrizi F; Bruchfeld A; Mangano S; Dixit V; Messa P; Martin P
Int J Artif Organs; 2007 Mar; 30(3):212-9. PubMed ID: 17417760
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adefovir dipivoxil combined with a corticosteroid in 38 cases of nephrotic syndrome induced by hepatitis B virus-associated glomerulonephritis.
Li H; Yuan X; Qiu L; Zhou Q; Xiao P
Ren Fail; 2014 Oct; 36(9):1404-6. PubMed ID: 25246340
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of anti-viral therapy for Hepatitis B virus-associated glomerulonephritis: A meta-analysis.
Fu B; Ji Y; Hu S; Ren T; Bhuva MS; Li G; Yang H
PLoS One; 2020; 15(1):e0227532. PubMed ID: 31940324
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis: anti-viral therapy of hepatitis B virus-associated glomerulonephritis.
Fabrizi F; Dixit V; Martin P
Aliment Pharmacol Ther; 2006 Sep; 24(5):781-8. PubMed ID: 16918881
[TBL] [Abstract][Full Text] [Related]
13. Seroconversion of hepatitis B envelope antigen by entecavir in a child with hepatitis B virus-related membranous nephropathy.
Igarashi T; Shimizu A; Igarashi T; Hanaoka K; Yoshizaki K; Shigemori T; Shimizu S; Komeichi H; Itoh Y
J Nippon Med Sch; 2013; 80(5):387-95. PubMed ID: 24189358
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of anti-viral therapy on hepatitis B virus-associated glomerulonephritis: A systematic review and meta-analysis.
Yi Z; Jie YW; Nan Z
Ann Hepatol; 2011; 10(2):165-73. PubMed ID: 21502678
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and Safety of Long-Term Corticosteroid Monotherapy in 26 Cases of Nephrotic Syndrome with Biopsy-Proven Membranous Nephropathy Induced by Seronegative Hepatitis B Virus-Associated Glomerulonephritis.
Zhang Y; Chen S; Yang D; Liu J; Zhang X; Yang X; Han H; Yang D
Nephron; 2021; 145(2):113-122. PubMed ID: 33561853
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.
Sun LJ; Shan JP; Cui RL; Yuan WJ; Jiang GR
Int Urol Nephrol; 2017 Jun; 49(6):1049-1056. PubMed ID: 28283858
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B-related glomerulonephritis and optimization of treatment.
Liu Y; Shi C; Fan J; Wang B; Li G
Expert Rev Gastroenterol Hepatol; 2020 Feb; 14(2):113-125. PubMed ID: 31951758
[No Abstract] [Full Text] [Related]
18. Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: a meta-analysis.
Su QM; Ye XG
World J Gastroenterol; 2012 Nov; 18(43):6290-301. PubMed ID: 23180951
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis of Antiviral Therapy for Hepatitis B Virus-Associated Membranous Nephropathy.
Yang Y; Ma YP; Chen DP; Zhuo L; Li WG
PLoS One; 2016; 11(9):e0160437. PubMed ID: 27598699
[TBL] [Abstract][Full Text] [Related]
20. Discontinuation of antiviral prophylaxis increased the risk of hepatitis B virus reactivation in glomerulonephritis patients under immunotherapy: a real-life observation.
Fang J; Li W; Tan M; Chen W; Zhang C; Wang W; Xu Q; Guo X
Int Urol Nephrol; 2018 Sep; 50(9):1653-1660. PubMed ID: 29644524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]